Station12
London, United Kingdom7
5
0.70
3
0.29
1
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- GBP 60000000
- Fund raised date
- 2018-03-07
Analytics
- Total investments
- 7
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 0.70
- Follow on index
- 0.29
- Investments by industry
- Higher Education (4)
- Software (3)
- E-Learning (2)
- Sports (2)
- Education (2) Show 4 more
- Investments by region
- Israel (1)
- United Kingdom (6)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Group Appearance index
- 0.14
- Avg. company exit year
- 6
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| GetTWOit | 01 Dec 2023 | Software, E-Learning, Higher Education | Seed | Liverpool, Liverpool, United Kingdom |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Canton Biologics | Sep 18, 2023 | Analytical Methodologies, Biopharmaceutical, Cell Line Development, CMC Development, Commercial Production, Expression Host Cells, Global Clinical Supply, High-Density Cell Culture, International Manufacturing, lgM Molecule Expression, New Formulations, Protein Expression | Growth stage | 300000000 CNY |  Guangzhou, Guangdong |
| Ractigen Therapeutics | Jan 28, 2022 | Oligonucleotide manufacturing, Pharmaceutical, RNAa technology, Therapies | Early stage | 30000000 USD | Nantong, Jiangsu |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.